If you would like to be added to the news release distribution list, please fill out the
email alerts form here
| June 23, 2010 |
Helix BioPharma Corp. Announces Positive Phase II Pharmacokinetic Findings For Topical Interferon Alpha-2B In Patients With Low-Grade Cervical Lesions
|
| June 11, 2010 |
Helix BioPharma Corp. Announces Fiscal Q3 2010 Results
|
| June 8, 2010 |
Helix BioPharma Corp Announces Phase II Clinical Trial Results of Topical Interferon Alpha-2B in Patients with Ano-Genital Warts
|
| April 5, 2010 |
Helix BioPharma To Present At The BioFinance 2010 Conference On April 7
|
| March 22, 2010 |
Helix BioPharma Corp. Achieves Last-Patient-Out In Its Phase II Trial Of Topical Interferon Alpha-2B In Patients With Ano-Genital Warts
|
| March 10, 2010 |
Helix BioPharma Corp. Announces Fiscal Q2 2010 Results
|
| February 12, 2010 |
Helix BioPharma Announces Positive Interim Results From Its Ongoing Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b In Patients With Low-Grade Cervical Lesions
|
| January 22, 2010 |
Helix BioPharma To Present at 7th Annual Bio Asia Partnering Conference on January 26
|
| January 7, 2010 |
Helix BioPharma to Present at Biotech Showcase 2010 on January 13
|
| December 9, 2009 |
Helix BioPharma Reports on 2009 Annual General Meeting
|
| December 9, 2009 |
Helix BioPharma Corp. Announces Fiscal Q1 2010 Results
|
| November 5, 2009 |
Helix BioPharma Corp Completes Enrollment In Its Phase II Trial Of Topical Interferon Alpha-2b In Patients With Ano-Genital Warts
|
| October 29, 2009 |
Helix BioPharma Corp. Announces Fiscal 2009 Results
|
| October 14, 2009 |
Helix BioPharma’s L-DOS47 To Be Highlighted at Pharmaceutical Industry Conference
|
| October 6, 2009 |
Helix BioPharma Provides Updates On Topical Interferon Alpha-2B and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
|
| September 8, 2009 |
Helix BioPharma Closes Private Placement
|
| September 4, 2009 |
Helix BioPharma Announces $13.5 Million Private Placement
|
| September 3, 2009 |
Helix BioPharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
|
| August 17, 2009 |
Helix BioPharma Announces the Appontment of Kazimierz Roszkowski-Śliż, M.D., PH.D., to its Board of Directors
|